High Frequency Episodic Migraine Shift to Low Frequency Episodic Migraine in Patients Treated with Galcanezumab

被引：0
|
作者：
Stauffer, Virginia [1 ]
Jedynak, Jakub [1 ]
Gendolla, Astrid [2 ]
Eross, Eric [3 ]
Jin, Leah [4 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Praxis Gendolla, Essen, Germany
[3] Phoenix Headache Inst, Phoenix, AZ USA
[4] Covance Inc, Princeton, NJ USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1772
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine
    Igarashi, Hisaka
    Shibata, Mamoru
    Ozeki, Akichika
    Day, Kathleen Ann
    Matsumura, Taka
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 3555 - 3564
  • [22] COMORBIDITIES IN LOW AND HIGH FREQUENCY EPISODIC AND CHRONIC MIGRAINE: A SUBGROUP ANALYSIS OF THE BECOME STUDY
    Watson, David
    Gaul, Charly
    Lucas, Christian
    Pozo-Rosich, Patricia
    Martelletti, Paolo
    Ritter, Shannon
    Snellman, Josefin
    CEPHALALGIA, 2020, 40 : 100 - 101
  • [23] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
    Stephen D. Silberstein
    Virginia L. Stauffer
    Katie A. Day
    Sarah Lipsius
    Maria-Carmen Wilson
    The Journal of Headache and Pain, 2019, 20
  • [24] Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
    Silberstein, Stephen D.
    Stauffer, Virginia L.
    Day, Katie A.
    Lipsius, Sarah
    Wilson, Maria-Carmen
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (1):
  • [25] Misused and Misleading: "100% Response Rate" to Galcanezumab in Patients With Episodic Migraine
    Steiner, Timothy J.
    Tfelt-Hansen, Peer
    HEADACHE, 2019, 59 (04): : 626 - 626
  • [26] Shift from Chronic Migraine to Episodic Migraine Status in a Long-Term Phase 3 Study of Galcanezumab
    Hindiyeh, N. A.
    Detke, H. C.
    Day, K.
    Lipsius, S.
    Aurora, S. K.
    Diener, H.
    HEADACHE, 2019, 59 : 103 - 103
  • [27] Shift from chronic migraine to episodic migraine status in a long-term phase 3 study of galcanezumab
    Detke, H.
    Day, K.
    Lipsius, S.
    Aurora, S. K.
    Hindiyeh, N.
    Diener, H-C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 425 - 425
  • [28] Onabotulinumtoxin A in high frequency episodic migraine: experience in a University Hospital.
    Sastre, M.
    Lara Lara, M.
    Diaz de Teran, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1086 - 1086
  • [29] Migraine frequency may be associated with increased interictal platelet activation in episodic migraine
    Jesurum, J. T.
    Fuller, C. J.
    Lucas, S. M.
    Murinova, N.
    Hales, L. E.
    McGee, E. A.
    CEPHALALGIA, 2009, 29 (12) : 1359 - 1359
  • [30] Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
    Stephen D. Silberstein
    Virginia L. Stauffer
    Katie A. Day
    Sarah Lipsius
    Maria-Carmen Wilson
    The Journal of Headache and Pain, 2019, 20
12345